T1	AdverseReaction 151 157	stroke
T2	AdverseReaction 159 184	transient ischemic attack
T3	AdverseReaction 113 143	cerebrovascular adverse events
T4	AdverseReaction 701 718	metabolic changes
T5	DrugClass 646 674	Atypical antipsychotic drugs
T6	AdverseReaction 737 751;768 772	cardiovascular risk
T7	AdverseReaction 752 772	cerebrovascular risk
T9	AdverseReaction 806 819	hyperglycemia
T10	AdverseReaction 821 833	dyslipidemia
T11	AdverseReaction 839 850	weight gain
T12	AdverseReaction 892 918	Hypersensitivity reactions
T13	AdverseReaction 930 941	anaphylaxis
T14	AdverseReaction 946 956	angioedema
T15	AdverseReaction 1055 1064	Dizziness
T16	AdverseReaction 1066 1077	tachycardia
T17	AdverseReaction 1081 1092	bradycardia
T18	Factor 1106 1109	may
T19	AdverseReaction 1280 1290	Leukopenia
T20	AdverseReaction 1292 1303	Neutropenia
T21	AdverseReaction 1309 1324	Agranulocytosis
T22	DrugClass 1349 1363	antipsychotics
T23	AdverseReaction 2446 2451	death
T25	DrugClass 2398 2417	antipsychotic drugs
T24	AdverseReaction 2600 2605	death
T26	DrugClass 2551 2579	atypical antipsychotic drugs
T27	AdverseReaction 2769 2774	death
T28	AdverseReaction 2894 2899	death
T30	AdverseReaction 2976 2989	heart failure
T31	AdverseReaction 2991 3003	sudden death
T32	AdverseReaction 3026 3035	pneumonia
T33	AdverseReaction 2925 2931	deaths
T37	AdverseReaction 3233 3252	increased mortality
T38	DrugClass 3303 3321	antipsychotic drug
T39	AdverseReaction 3798 3831	cerebrovascular adverse reactions
T40	AdverseReaction 3833 3858	cerebrovascular accidents
T41	AdverseReaction 3863 3889	transient ischemic attacks
T42	AdverseReaction 3901 3911	fatalities
T43	DrugClass 3689 3700	risperidone
T44	DrugClass 3702 3714	aripiprazole
T45	DrugClass 3720 3730	olanzapine
T46	AdverseReaction 4211 4241	Neuroleptic Malignant Syndrome
T47	AdverseReaction 4243 4246	NMS
T48	Factor 4152 4163	potentially
T49	AdverseReaction 4371 4374	NMS
T50	AdverseReaction 4379 4391	hyperpyrexia
T51	AdverseReaction 4393 4408	muscle rigidity
T52	AdverseReaction 4410 4431	altered mental status
T53	AdverseReaction 4449 4470	autonomic instability
T54	AdverseReaction 4472 4487	irregular pulse
T55	AdverseReaction 4472 4481;4491 4505	irregular blood pressure
T56	AdverseReaction 4507 4518	tachycardia
T57	AdverseReaction 4520 4531	diaphoresis
T58	AdverseReaction 4537 4556	cardiac dysrhythmia
T59	AdverseReaction 4588 4619	elevated creatine phosphokinase
T60	AdverseReaction 4621 4634	myoglobinuria
T61	Factor 4576 4579	may
T62	AdverseReaction 4636 4650	rhabdomyolysis
T63	AdverseReaction 4657 4676	acute renal failure
T64	AdverseReaction 5886 5919	involuntary, dyskinetic movements
T65	Severity 5860 5884	potentially irreversible
T66	DrugClass 5957 5976	antipsychotic drugs
T68	AdverseReaction 6315 6333	Tardive Dyskinesia
T69	AdverseReaction 6335 6337	TD
T70	DrugClass 6252 6270	antipsychotic drug
T72	AdverseReaction 6382 6384	TD
T74	DrugClass 6524 6543	antipsychotic drugs
T75	Severity 6424 6436	irreversible
T78	AdverseReaction 8083 8100	metabolic changes
T79	AdverseReaction 8110 8133;8150 8154	increase cardiovascular risk
T80	AdverseReaction 8110 8118;8134 8154	increase cerebrovascular risk
T82	DrugClass 8028 8056	Atypical antipsychotic drugs
T83	AdverseReaction 8188 8201	hyperglycemia
T84	AdverseReaction 8203 8215	dyslipidemia
T85	AdverseReaction 8221 8237	body weight gain
T86	AdverseReaction 8162 8179	metabolic changes
T87	AdverseReaction 8307 8324	metabolic changes
T88	DrugClass 8256 8274	drugs in the class
T89	DrugClass 8573 8596	atypical antipsychotics
T90	AdverseReaction 8429 8442	Hyperglycemia
T91	Severity 8458 8465	extreme
T92	AdverseReaction 8486 8498	ketoacidosis
T93	AdverseReaction 8502 8519	hyperosmolar coma
T94	AdverseReaction 8523 8528	death
T95	DrugClass 9183 9206	atypical antipsychotics
T96	AdverseReaction 9117 9130	hyperglycemia
T98	AdverseReaction 9261 9274	hyperglycemia
T99	DrugClass 9323 9346	atypical antipsychotics
T101	AdverseReaction 12039 12047;12062 12080	increase of fasting glucose
T102	AdverseReaction 13019 13031	Dyslipidemia
T103	AdverseReaction 13042 13075	Undesirable alterations in lipids
T104	DrugClass 13120 13143	atypical antipsychotics
T105	AdverseReaction 15049 15077	total cholesterol elevations
T106	AdverseReaction 15214 15241	elevations in triglycerides
T107	AdverseReaction 15438 15466	total cholesterol elevations
T108	AdverseReaction 15605 15632	elevations in triglycerides
T109	AdverseReaction 17594 17613	Increases in weight
T110	AdverseReaction 17908 17919	weight gain
T111	AdverseReaction 19072 19083	weight gain
T112	AdverseReaction 19149 19172	increase in body weight
T113	AdverseReaction 19222 19235	weight change
T114	AdverseReaction 19288 19299	weight gain
T115	AdverseReaction 19755 19778	increase in body weight
T116	AdverseReaction 19915 19937	changes in body weight
T117	AdverseReaction 19989 20000	weight gain
T118	AdverseReaction 21291 21314	Increase in Body Weight
T119	AdverseReaction 21502 21528	Hypersensitivity reactions
T120	AdverseReaction 21653 21679	hypersensitivity reactions
T121	AdverseReaction 21690 21701	anaphylaxis
T122	AdverseReaction 21715 21726	hypotension
T123	AdverseReaction 21703 21713	angioedema
T124	AdverseReaction 21728 21739	tachycardia
T125	AdverseReaction 21741 21755	swollen tongue
T126	AdverseReaction 21757 21764	dyspnea
T127	AdverseReaction 21766 21774	wheezing
T128	AdverseReaction 21779 21783	rash
T129	AdverseReaction 21889 21912	orthostatic hypotension
T130	Factor 21878 21881	may
T131	AdverseReaction 21917 21924	syncope
T132	AdverseReaction 22070 22077	syncope
T133	AdverseReaction 22291 22298	syncope
T134	AdverseReaction 22583 22590	syncope
T135	AdverseReaction 22700 22707	syncope
T136	AdverseReaction 24113 24123	leukopenia
T137	AdverseReaction 24128 24139	neutropenia
T138	AdverseReaction 24222 24237	Agranulocytosis
T139	AdverseReaction 24249 24254	fatal
T140	DrugClass 24285 24310	other agents in the class
T143	AdverseReaction 25576 25601	increases in QTc interval
T144	Severity 25615 25616;25622 25626	2 msec
T145	Severity 25620 25626	5 msec
T146	Severity 25615 25626	2 to 5 msec
T147	AdverseReaction 25693 25706	QTc increases
T148	Severity 25709 25716	60 msec
T149	Negation 25648 25650	No
T150	AdverseReaction 25778 25795	QTc of >=500 msec
T152	AdverseReaction 25967 25983	QT prolongations
T153	AdverseReaction 26114 26132	Torsade de Pointes
T154	Negation 26100 26102	no
T155	AdverseReaction 26180 26214	delayed ventricular repolarization
T156	AdverseReaction 27051 27075	elevate prolactin levels
T157	Factor 27047 27050	can
T159	AdverseReaction 27138 27156	Hyperprolactinemia
T160	AdverseReaction 27161 27187	suppress hypothalamic GnRH
T161	AdverseReaction 27202 27242	reduced pituitary gonadotropin secretion
T162	AdverseReaction 27263 27292	inhibit reproductive function
T163	Factor 27259 27262	may
T164	AdverseReaction 27296 27329	impairing gonadal steroidogenesis
T165	AdverseReaction 27364 27376	Galactorrhea
T166	AdverseReaction 27378 27388	amenorrhea
T167	AdverseReaction 27390 27402	gynecomastia
T168	AdverseReaction 27408 27417	impotence
T169	DrugClass 27459 27488	prolactin-elevating compounds
T170	AdverseReaction 27504 27522	hyperprolactinemia
T171	AdverseReaction 27544 27556	hypogonadism
T172	AdverseReaction 27569 27591	decreased bone density
T173	Factor 27557 27560	may
T174	AdverseReaction 27704 27729	abnormal prolactin levels
T175	AdverseReaction 27850 27875	abnormal prolactin levels
T176	AdverseReaction 28662 28670	Seizures
T177	AdverseReaction 29054 29062	seizures
T178	AdverseReaction 29153 29161	seizures
T179	Negation 29139 29141	no
T180	AdverseReaction 29591 29601	Somnolence
T181	AdverseReaction 29820 29830	somnolence
T182	AdverseReaction 30111 30121	somnolence
T183	AdverseReaction 30334 30344	somnolence
T184	AdverseReaction 30410 30420	Somnolence
T185	AdverseReaction 30432 30440	sedation
T186	AdverseReaction 30622 30632	somnolence
T187	AdverseReaction 30644 30652	sedation
T188	AdverseReaction 30657 30668	hypersomnia
T189	AdverseReaction 30828 30838	Somnolence
T190	AdverseReaction 31303 31367	Disruption of the body's ability to reduce core body temperature
T191	DrugClass 31391 31411	antipsychotic agents
T192	AdverseReaction 31557 31583	body temperature increases
T193	AdverseReaction 31775 31801	body temperature increases
T194	AdverseReaction 31803 31810	pyrexia
T195	AdverseReaction 31815 31826	feeling hot
T196	AdverseReaction 32552 32574	Esophageal dysmotility
T197	AdverseReaction 32579 32589	aspiration
T198	DrugClass 32616 32634	antipsychotic drug
T199	AdverseReaction 32640 32649	Dysphagia
T200	AdverseReaction 33024 33033	dysphagia
T201	Severity 15080 15089	240 mg/dL
T202	Severity 15244 15253	200 mg/dL
T203	Severity 15469 15478	240 mg/dL
T204	Severity 15635 15644	200 mg/dL
T205	Severity 19146 19148	7%
T206	Severity 19305 19307	7%
T207	Severity 20016 20018	7%
T208	Severity 21288 21290	7%
T209	AdverseReaction 21331 21354	increase in body weight
T210	Severity 21328 21330	7%
T211	AdverseReaction 307 337	Neuroleptic Malignant Syndrome
T212	AdverseReaction 411 429	Tardive Dyskinesia
T213	AdverseReaction 1716 1740	Increases in QT interval
T214	AdverseReaction 1871 1879	Seizures
T215	AdverseReaction 2015 2024;2035 2045	Cognitive Impairment
T216	Factor 2001 2010	Potential
T217	AdverseReaction 2029 2045	Motor Impairment
T218	AdverseReaction 2098 2105	Suicide
T219	DrugClass 265 293	atypical antipsychotic drugs
T220	AdverseReaction 780 797	metabolic changes
T221	AdverseReaction 1098 1105	syncope
T222	AdverseReaction 4164 4169	fatal
T76	AdverseReaction 8966 8979	hyperglycemia
T77	DrugClass 8935 8957	atypical antipsychotic
T223	Severity 17935 17937	7%
T224	AdverseReaction 18753 18776	Increase in Body Weight
T225	Severity 18750 18752	7%
T226	AdverseReaction 18793 18816	increase in body weight
T227	Severity 18790 18792	7%
T228	Severity 19752 19754	7%
T141	Negation 25745 25748	nor
T142	Severity 25994 26002	500 msec
T158	Factor 27157 27160	may
T229	AdverseReaction 28546 28559	tumorigenesis
T230	Negation 28393 28400;28418 28421	Neither nor
T232	AdverseReaction 55 85	Cerebrovascular Adverse Events
T233	AdverseReaction 627 644	Metabolic Changes
T234	AdverseReaction 864 890	Hypersensitivity Reactions
T235	AdverseReaction 990 1013	Orthostatic Hypotension
T236	AdverseReaction 1015 1022	Syncope
T237	AdverseReaction 1034 1053	Hemodynamic Effects
T238	AdverseReaction 1699 1714	QT Prolongation
E1	AdverseReaction:T1 Hypothetical:E222
E2	AdverseReaction:T2 Hypothetical:E222
E3	AdverseReaction:T3 Hypothetical:E222
E4	AdverseReaction:T4 Hypothetical:E5
E5	DrugClass:T5
E6	AdverseReaction:T6 Hypothetical2:E5
E7	AdverseReaction:T7 Hypothetical2:E5
E9	AdverseReaction:T9 Hypothetical:E5
E10	AdverseReaction:T10 Hypothetical:E5
E11	AdverseReaction:T11 Hypothetical:E5
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15 Hypothetical:E18
E16	AdverseReaction:T16 Hypothetical:E18
E17	AdverseReaction:T17 Hypothetical:E18
E18	Factor:T18
E19	AdverseReaction:T19 Hypothetical:E22
E20	AdverseReaction:T20 Hypothetical:E22
E21	AdverseReaction:T21 Hypothetical:E22
E22	DrugClass:T22
E23	AdverseReaction:T23 Hypothetical:E25
E25	DrugClass:T25
E24	AdverseReaction:T24 Hypothetical:E26
E26	DrugClass:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E38	AdverseReaction:T37 Hypothetical:E39
E39	DrugClass:T38
E40	AdverseReaction:T39 Hypothetical:E46 Hypothetical2:E45 Hypothetical3:E44
E41	AdverseReaction:T40 Hypothetical:E44 Hypothetical2:E45 Hypothetical3:E46
E42	AdverseReaction:T41 Hypothetical:E44 Hypothetical2:E45 Hypothetical3:E46
E43	AdverseReaction:T42 Hypothetical:E44 Hypothetical2:E45 Hypothetical3:E46
E44	DrugClass:T43
E45	DrugClass:T44
E46	DrugClass:T45
E47	AdverseReaction:T46
E48	AdverseReaction:T47
E49	Factor:T48
E50	AdverseReaction:T49
E51	AdverseReaction:T50
E52	AdverseReaction:T51
E53	AdverseReaction:T52
E54	AdverseReaction:T53
E55	AdverseReaction:T54
E56	AdverseReaction:T55
E57	AdverseReaction:T56
E58	AdverseReaction:T57
E59	AdverseReaction:T58
E60	AdverseReaction:T59 Hypothetical:E62
E61	AdverseReaction:T60 Hypothetical:E62
E62	Factor:T61
E63	AdverseReaction:T62 Hypothetical:E62
E64	AdverseReaction:T63 Hypothetical:E62
E65	AdverseReaction:T64 Effect:E66 Hypothetical:E67
E66	Severity:T65
E67	DrugClass:T66
E69	AdverseReaction:T68 Hypothetical:E71
E70	AdverseReaction:T69 Hypothetical:E71
E71	DrugClass:T70
E73	AdverseReaction:T72 Hypothetical2:E75 Effect:E77
E75	DrugClass:T74
E76	AdverseReaction:T72 Hypothetical2:E75
E77	Severity:T75
E80	AdverseReaction:T78 Hypothetical:E84
E81	AdverseReaction:T79 Hypothetical2:E84
E82	AdverseReaction:T80 Hypothetical2:E84
E84	DrugClass:T82
E85	AdverseReaction:T83 Hypothetical:E84
E86	AdverseReaction:T84 Hypothetical:E84
E87	AdverseReaction:T85 Hypothetical:E84
E88	AdverseReaction:T86 Hypothetical:E84
E89	AdverseReaction:T87 Hypothetical:E90
E90	DrugClass:T88
E91	DrugClass:T89
E92	AdverseReaction:T90 Hypothetical:E91
E93	AdverseReaction:T90 Effect:E94 Hypothetical:E91
E94	Severity:T91
E95	AdverseReaction:T92 Hypothetical:E91
E96	AdverseReaction:T93 Hypothetical:E91
E97	AdverseReaction:T94 Hypothetical:E91
E98	DrugClass:T95
E99	AdverseReaction:T96 Hypothetical2:E98
E101	AdverseReaction:T98 Hypothetical2:E102
E102	DrugClass:T99
E104	AdverseReaction:T101
E105	AdverseReaction:T102 Hypothetical:E107
E106	AdverseReaction:T103 Hypothetical:E107
E107	DrugClass:T104
E108	AdverseReaction:T105 Effect:E204
E109	AdverseReaction:T106 Effect:E205
E110	AdverseReaction:T107 Effect:E206
E111	AdverseReaction:T108 Effect:E207
E112	AdverseReaction:T109
E113	AdverseReaction:T110 Effect:E225
E114	AdverseReaction:T111
E115	AdverseReaction:T112 Effect:E208
E116	AdverseReaction:T113
E117	AdverseReaction:T114 Effect:E209
E118	AdverseReaction:T115 Effect:E230
E119	AdverseReaction:T116
E120	AdverseReaction:T117 Effect:E210
E121	AdverseReaction:T118 Effect:E211
E122	AdverseReaction:T119
E123	AdverseReaction:T120
E124	AdverseReaction:T121
E125	AdverseReaction:T122
E126	AdverseReaction:T123
E127	AdverseReaction:T124
E128	AdverseReaction:T125
E129	AdverseReaction:T126
E130	AdverseReaction:T127
E131	AdverseReaction:T128
E132	AdverseReaction:T129 Hypothetical:E133
E133	Factor:T130
E134	AdverseReaction:T131 Hypothetical:E133
E135	AdverseReaction:T132
E136	AdverseReaction:T133
E137	AdverseReaction:T134
E138	AdverseReaction:T135
E139	AdverseReaction:T136
E140	AdverseReaction:T137
E141	AdverseReaction:T138 Hypothetical:E143
E142	AdverseReaction:T139 Hypothetical:E143
E143	DrugClass:T140
E146	AdverseReaction:T143 Effect:E149 Effect2:E148 Effect3:E147
E147	Severity:T144
E148	Severity:T145
E149	Severity:T146
E150	AdverseReaction:T147 Effect:E151 Negated:E152
E151	Severity:T148
E152	Negation:T149
E153	AdverseReaction:T150 Negated:E144
E155	AdverseReaction:T152 Effect:E145
E156	AdverseReaction:T153 Negated:E157
E157	Negation:T154
E158	AdverseReaction:T155 Negated:E157
E159	AdverseReaction:T156 Hypothetical:E160
E160	Factor:T157
E162	AdverseReaction:T159
E163	AdverseReaction:T160 Hypothetical:E161
E164	AdverseReaction:T161 Hypothetical:E161
E165	AdverseReaction:T162 Hypothetical:E166
E166	Factor:T163
E167	AdverseReaction:T164
E168	AdverseReaction:T165 Hypothetical:E172
E169	AdverseReaction:T166 Hypothetical:E172
E170	AdverseReaction:T167 Hypothetical:E172
E171	AdverseReaction:T168 Hypothetical:E172
E172	DrugClass:T169
E173	AdverseReaction:T170
E174	AdverseReaction:T171
E175	AdverseReaction:T172 Hypothetical:E176
E176	Factor:T173
E177	AdverseReaction:T174
E178	AdverseReaction:T175
E179	AdverseReaction:T176
E180	AdverseReaction:T177
E181	AdverseReaction:T178 Negated:E182
E182	Negation:T179
E183	AdverseReaction:T180
E184	AdverseReaction:T181
E185	AdverseReaction:T182
E186	AdverseReaction:T183
E187	AdverseReaction:T184
E188	AdverseReaction:T185
E189	AdverseReaction:T186
E190	AdverseReaction:T187
E191	AdverseReaction:T188
E192	AdverseReaction:T189
E193	AdverseReaction:T190 Hypothetical:E194
E194	DrugClass:T191
E195	AdverseReaction:T192
E196	AdverseReaction:T193
E197	AdverseReaction:T194
E198	AdverseReaction:T195
E199	AdverseReaction:T196 Hypothetical:E201
E200	AdverseReaction:T197 Hypothetical:E201
E201	DrugClass:T198
E202	AdverseReaction:T199
E203	AdverseReaction:T200
E204	Severity:T201
E205	Severity:T202
E206	Severity:T203
E207	Severity:T204
E208	Severity:T205
E209	Severity:T206
E210	Severity:T207
E211	Severity:T208
E212	AdverseReaction:T209 Effect:E213
E213	Severity:T210
E214	AdverseReaction:T211
E215	AdverseReaction:T212
E216	AdverseReaction:T213
E217	AdverseReaction:T214
E218	AdverseReaction:T215 Hypothetical:E219
E219	Factor:T216
E220	AdverseReaction:T217 Hypothetical:E219
E221	AdverseReaction:T218
E222	DrugClass:T219
E223	AdverseReaction:T220 Hypothetical:E5
E224	AdverseReaction:T221 Hypothetical:E18
E29	AdverseReaction:T222 Hypothetical:E49
E78	AdverseReaction:T76 Hypothetical:E79
E79	DrugClass:T77
E225	Severity:T223
E226	AdverseReaction:T224 Effect:E227
E227	Severity:T225
E228	AdverseReaction:T226 Effect:E229
E229	Severity:T227
E230	Severity:T228
E144	Negation:T141
E145	Severity:T142
E161	Factor:T158
E231	AdverseReaction:T229 Negated:E232
E232	Negation:T230
E234	AdverseReaction:T232
E235	AdverseReaction:T233
E236	AdverseReaction:T234
E237	AdverseReaction:T235
E238	AdverseReaction:T236
E239	AdverseReaction:T237
E240	AdverseReaction:T238
A1	CUI E1 C0038454
A2	UMLS-Preferred-Name E1 Cerebrovascular accident
A3	MEDDRA-PT E1 Cerebrovascular accident
A4	MEDDRA-PT-ID E1 10008190
A5	LLT E1 Stroke
A6	LLT-ID E1 10042244
A7	CUI E2 C0007787
A8	UMLS-Preferred-Name E2 Transient Ischemic Attack
A9	MEDDRA-PT E2 Transient ischaemic attack
A10	MEDDRA-PT-ID E2 10044390
A11	LLT E2 Transient ischemic attack
A12	LLT-ID E2 10072760
A13	CUI E3 C0007820
A14	UMLS-Preferred-Name E3 Cerebrovascular Disorders
A15	MEDDRA-PT E3 Cerebrovascular disorder
A16	MEDDRA-PT-ID E3 10008196
A17	CUI E4 C0025517
A18	UMLS-Preferred-Name E4 Metabolic Diseases
A19	MEDDRA-PT E4 Metabolic disorder
A20	MEDDRA-PT-ID E4 10058097
A21	CUI E6 C0850624
A22	UMLS-Preferred-Name E6 cardiovascular risk factor
A23	MEDDRA-PT E6 Cardiovascular symptom
A24	MEDDRA-PT-ID E6 10075534
A25	CUI E7 C0007820
A26	UMLS-Preferred-Name E7 Cerebrovascular Disorders
A27	MEDDRA-PT E7 Cerebrovascular disorder
A28	MEDDRA-PT-ID E7 10008196
A29	CUI E9 C0020456
A30	UMLS-Preferred-Name E9 Hyperglycemia
A31	MEDDRA-PT E9 Hyperglycaemia
A32	MEDDRA-PT-ID E9 10020635
A33	LLT E9 Hyperglycemia
A34	LLT-ID E9 10020639
A35	CUI E10 C0242339
A36	UMLS-Preferred-Name E10 Dyslipidemias
A37	MEDDRA-PT E10 Dyslipidaemia
A38	MEDDRA-PT-ID E10 10058108
A39	LLT E10 Dyslipidemia
A40	LLT-ID E10 10058110
A41	CUI E11 C0043094
A42	UMLS-Preferred-Name E11 Weight Gain
A43	MEDDRA-PT E11 Weight increased
A44	MEDDRA-PT-ID E11 10047899
A45	LLT E11 Weight gain
A46	LLT-ID E11 10047896
A47	CUI E12 C0020517
A48	UMLS-Preferred-Name E12 Hypersensitivity
A49	MEDDRA-PT E12 Hypersensitivity
A50	MEDDRA-PT-ID E12 10020751
A51	LLT E12 Hypersensitivity reaction
A52	LLT-ID E12 10020756
A53	CUI E13 C0002792
A54	UMLS-Preferred-Name E13 anaphylaxis
A55	MEDDRA-PT E13 Anaphylactic reaction
A56	MEDDRA-PT-ID E13 10002198
A57	LLT E13 Anaphylaxis
A58	LLT-ID E13 10002218
A59	CUI E14 C0002994
A60	UMLS-Preferred-Name E14 Angioedema
A61	MEDDRA-PT E14 Angioedema
A62	MEDDRA-PT-ID E14 10002424
A63	CUI E15 C0012833
A64	UMLS-Preferred-Name E15 Dizziness
A65	MEDDRA-PT E15 Dizziness
A66	MEDDRA-PT-ID E15 10013573
A67	CUI E16 C0039231
A68	UMLS-Preferred-Name E16 Tachycardia
A69	MEDDRA-PT E16 Tachycardia
A70	MEDDRA-PT-ID E16 10043071
A71	CUI E17 C0428977
A72	UMLS-Preferred-Name E17 Bradycardia
A73	MEDDRA-PT E17 Bradycardia
A74	MEDDRA-PT-ID E17 10006093
A75	CUI E19 C0023530
A76	UMLS-Preferred-Name E19 Leukopenia
A77	MEDDRA-PT E19 Leukopenia
A78	MEDDRA-PT-ID E19 10024384
A79	CUI E20 C0027947
A80	UMLS-Preferred-Name E20 Neutropenia
A81	MEDDRA-PT E20 Neutropenia
A82	MEDDRA-PT-ID E20 10029354
A83	CUI E21 C0001824
A84	UMLS-Preferred-Name E21 Agranulocytosis
A85	MEDDRA-PT E21 Agranulocytosis
A86	MEDDRA-PT-ID E21 10001507
A87	CUI E23 C1306577
A88	UMLS-Preferred-Name E23 Death (finding)
A89	MEDDRA-PT E23 Death
A90	MEDDRA-PT-ID E23 10011906
A91	CUI E24 C1306577
A92	UMLS-Preferred-Name E24 Death (finding)
A93	MEDDRA-PT E24 Death
A94	MEDDRA-PT-ID E24 10011906
A95	CUI E27 C1306577
A96	UMLS-Preferred-Name E27 Death (finding)
A97	MEDDRA-PT E27 Death
A98	MEDDRA-PT-ID E27 10011906
A99	CUI E28 C1306577
A100	UMLS-Preferred-Name E28 Death (finding)
A101	MEDDRA-PT E28 Death
A102	MEDDRA-PT-ID E28 10011906
A103	CUI E30 C0018801
A104	UMLS-Preferred-Name E30 Heart failure
A105	MEDDRA-PT E30 Cardiac failure
A106	MEDDRA-PT-ID E30 10007554
A107	LLT E30 Heart failure
A108	LLT-ID E30 10019279
A109	CUI E31 C0011071
A110	UMLS-Preferred-Name E31 Sudden death
A111	MEDDRA-PT E31 Sudden death
A112	MEDDRA-PT-ID E31 10042434
A113	CUI E32 C0032285
A114	UMLS-Preferred-Name E32 Pneumonia
A115	MEDDRA-PT E32 Pneumonia
A116	MEDDRA-PT-ID E32 10035664
A117	CUI E33 C1306577
A118	UMLS-Preferred-Name E33 Death (finding)
A119	MEDDRA-PT E33 Death
A120	MEDDRA-PT-ID E33 10011906
A121	CUI E38 C1306577
A122	UMLS-Preferred-Name E38 Death (finding)
A123	MEDDRA-PT E38 Death
A124	MEDDRA-PT-ID E38 10011906
A125	CUI E40 C0007820
A126	UMLS-Preferred-Name E40 Cerebrovascular Disorders
A127	MEDDRA-PT E40 Cerebrovascular disorder
A128	MEDDRA-PT-ID E40 10008196
A129	CUI E41 C0038454
A130	UMLS-Preferred-Name E41 Cerebrovascular accident
A131	MEDDRA-PT E41 Cerebrovascular accident
A132	MEDDRA-PT-ID E41 10008190
A133	CUI E42 C0007787
A134	UMLS-Preferred-Name E42 Transient Ischemic Attack
A135	MEDDRA-PT E42 Transient ischaemic attack
A136	MEDDRA-PT-ID E42 10044390
A137	LLT E42 Transient ischemic attacks
A138	LLT-ID E42 10044391
A139	CUI E43 C1306577
A140	UMLS-Preferred-Name E43 Death (finding)
A141	MEDDRA-PT E43 Death
A142	MEDDRA-PT-ID E43 10011906
A143	CUI E47 C0027849
A144	UMLS-Preferred-Name E47 Neuroleptic Malignant Syndrome
A145	MEDDRA-PT E47 Neuroleptic malignant syndrome
A146	MEDDRA-PT-ID E47 10029282
A147	CUI E48 C0027849
A148	UMLS-Preferred-Name E48 Neuroleptic Malignant Syndrome
A149	MEDDRA-PT E48 Neuroleptic malignant syndrome
A150	MEDDRA-PT-ID E48 10029282
A151	LLT E48 NMS
A152	LLT-ID E48 10029435
A153	CUI E50 C0027849
A154	UMLS-Preferred-Name E50 Neuroleptic Malignant Syndrome
A155	MEDDRA-PT E50 Neuroleptic malignant syndrome
A156	MEDDRA-PT-ID E50 10029282
A157	LLT E50 NMS
A158	LLT-ID E50 10029435
A159	CUI E51 C0392676
A160	UMLS-Preferred-Name E51 Hyperpyrexia
A161	MEDDRA-PT E51 Hyperpyrexia
A162	MEDDRA-PT-ID E51 10020741
A163	CUI E52 C0026837
A164	UMLS-Preferred-Name E52 Muscle Rigidity
A165	MEDDRA-PT E52 Muscle rigidity
A166	MEDDRA-PT-ID E52 10028330
A167	CUI E53 C0856054
A168	UMLS-Preferred-Name E53 Mental status changes
A169	MEDDRA-PT E53 Mental status changes
A170	MEDDRA-PT-ID E53 10048294
A171	CUI E54 C0262385
A172	UMLS-Preferred-Name E54 Autonomic nervous system imbalance
A173	MEDDRA-PT E54 Autonomic nervous system imbalance
A174	MEDDRA-PT-ID E54 10003840
A175	LLT E54 Autonomic instability
A176	LLT-ID E54 10049218
A177	CUI E55 C0392684
A178	UMLS-Preferred-Name E55 Pulse irregular
A179	MEDDRA-PT E55 Heart rate irregular
A180	MEDDRA-PT-ID E55 10019304
A181	LLT E55 Irregular pulse
A182	LLT-ID E55 10022994
A183	CUI E56 C0549405
A184	UMLS-Preferred-Name E56 Blood pressure fluctuation
A185	MEDDRA-PT E56 Blood pressure fluctuation
A186	MEDDRA-PT-ID E56 10005746
A187	CUI E57 C0039231
A188	UMLS-Preferred-Name E57 Tachycardia
A189	MEDDRA-PT E57 Tachycardia
A190	MEDDRA-PT-ID E57 10043071
A191	CUI E58 C0700590
A192	UMLS-Preferred-Name E58 Increased sweating
A193	MEDDRA-PT E58 Hyperhidrosis
A194	MEDDRA-PT-ID E58 10020642
A195	LLT E58 Diaphoresis
A196	LLT-ID E58 10012703
A197	CUI E59 C0003811
A198	UMLS-Preferred-Name E59 Cardiac Arrhythmia
A199	MEDDRA-PT E59 Arrhythmia
A200	MEDDRA-PT-ID E59 10003119
A201	LLT E59 Cardiac dysrhythmias
A202	LLT-ID E59 10007545
A203	CUI E60 C0151576
A204	UMLS-Preferred-Name E60 Elevated creatine kinase
A205	MEDDRA-PT E60 Blood creatine phosphokinase increased
A206	MEDDRA-PT-ID E60 10005470
A207	LLT E60 Creatine phosphokinase increased
A208	LLT-ID E60 10011349
A209	CUI E61 C0027080
A210	UMLS-Preferred-Name E61 Myoglobinuria
A211	MEDDRA-PT E61 Myoglobinuria
A212	MEDDRA-PT-ID E61 10028629
A213	CUI E63 C0035410
A214	UMLS-Preferred-Name E63 Rhabdomyolysis
A215	MEDDRA-PT E63 Rhabdomyolysis
A216	MEDDRA-PT-ID E63 10039020
A217	CUI E64 C0022660
A218	UMLS-Preferred-Name E64 Kidney Failure, Acute
A219	MEDDRA-PT E64 Acute kidney injury
A220	MEDDRA-PT-ID E64 10069339
A221	LLT E64 Acute renal failure
A222	LLT-ID E64 10001041
A223	CUI E65 C0427086
A224	UMLS-Preferred-Name E65 Involuntary Movements
A225	MEDDRA-PT E65 Dyskinesia
A226	MEDDRA-PT-ID E65 10013916
A227	LLT E65 Movements involuntary
A228	LLT-ID E65 10028041
A229	CUI E69 C0686347
A230	UMLS-Preferred-Name E69 Tardive Dyskinesia
A231	MEDDRA-PT E69 Tardive dyskinesia
A232	MEDDRA-PT-ID E69 10043118
A233	CUI E70 C0686347
A234	UMLS-Preferred-Name E70 Tardive Dyskinesia
A235	MEDDRA-PT E70 Tardive dyskinesia
A236	MEDDRA-PT-ID E70 10043118
A237	CUI E73 C0686347
A238	UMLS-Preferred-Name E73 Tardive Dyskinesia
A239	MEDDRA-PT E73 Tardive dyskinesia
A240	MEDDRA-PT-ID E73 10043118
A241	CUI E80 C0025517
A242	UMLS-Preferred-Name E80 Metabolic Diseases
A243	MEDDRA-PT E80 Metabolic disorder
A244	MEDDRA-PT-ID E80 10058097
A245	flag E81 unmapped
A246	CUI E81 C0850624
A247	UMLS-Preferred-Name E81 cardiovascular risk factor
A248	flag E82 unmapped
A249	CUI E85 C0020456
A250	UMLS-Preferred-Name E85 Hyperglycemia
A251	MEDDRA-PT E85 Hyperglycaemia
A252	MEDDRA-PT-ID E85 10020635
A253	LLT E85 Hyperglycemia
A254	LLT-ID E85 10020639
A255	CUI E86 C0242339
A256	UMLS-Preferred-Name E86 Dyslipidemias
A257	MEDDRA-PT E86 Dyslipidaemia
A258	MEDDRA-PT-ID E86 10058108
A259	LLT E86 Dyslipidemia
A260	LLT-ID E86 10058110
A261	CUI E87 C0043094
A262	UMLS-Preferred-Name E87 Weight Gain
A263	MEDDRA-PT E87 Weight increased
A264	MEDDRA-PT-ID E87 10047899
A265	LLT E87 Weight gain
A266	LLT-ID E87 10047896
A267	CUI E88 C0025517
A268	UMLS-Preferred-Name E88 Metabolic Diseases
A269	MEDDRA-PT E88 Metabolic disorder
A270	MEDDRA-PT-ID E88 10058097
A271	CUI E89 C0025517
A272	UMLS-Preferred-Name E89 Metabolic Diseases
A273	MEDDRA-PT E89 Metabolic disorder
A274	MEDDRA-PT-ID E89 10058097
A275	CUI E92 C0020456
A276	UMLS-Preferred-Name E92 Hyperglycemia
A277	MEDDRA-PT E92 Hyperglycaemia
A278	MEDDRA-PT-ID E92 10020635
A279	LLT E92 Hyperglycemia
A280	LLT-ID E92 10020639
A281	CUI E95 C0220982
A282	UMLS-Preferred-Name E95 Ketoacidosis
A283	MEDDRA-PT E95 Ketoacidosis
A284	MEDDRA-PT-ID E95 10023379
A285	flag E96 duplicate
A286	CUI E96 C0020457
A287	UMLS-Preferred-Name E96 Hyperglycemic Hyperosmolar Nonketotic Coma
A288	MEDDRA-PT E96 Hyperosmolar state
A289	MEDDRA-PT-ID E96 10020697
A290	CUI E97 C1306577
A291	UMLS-Preferred-Name E97 Death (finding)
A292	MEDDRA-PT E97 Death
A293	MEDDRA-PT-ID E97 10011906
A294	CUI E99 C0020456
A295	UMLS-Preferred-Name E99 Hyperglycemia
A296	MEDDRA-PT E99 Hyperglycaemia
A297	MEDDRA-PT-ID E99 10020635
A298	LLT E99 Hyperglycemia
A299	LLT-ID E99 10020639
A300	CUI E101 C0020456
A301	UMLS-Preferred-Name E101 Hyperglycemia
A302	MEDDRA-PT E101 Hyperglycaemia
A303	MEDDRA-PT-ID E101 10020635
A304	LLT E101 Hyperglycemia
A305	LLT-ID E101 10020639
A306	CUI E104 C0920108
A307	UMLS-Preferred-Name E104 Fasting blood glucose increased
A308	MEDDRA-PT E104 Blood glucose increased
A309	MEDDRA-PT-ID E104 10005557
A310	LLT E104 Fasting blood glucose increased
A311	LLT-ID E104 10050786
A312	CUI E105 C0242339
A313	UMLS-Preferred-Name E105 Dyslipidemias
A314	MEDDRA-PT E105 Dyslipidaemia
A315	MEDDRA-PT-ID E105 10058108
A316	LLT E105 Dyslipidemia
A317	LLT-ID E105 10058110
A318	CUI E106 C0549634
A319	UMLS-Preferred-Name E106 Lipids abnormal
A320	MEDDRA-PT E106 Lipids abnormal
A321	MEDDRA-PT-ID E106 10024588
A322	CUI E108 C1522133
A323	UMLS-Preferred-Name E108 Hypercholesterolemia result
A324	MEDDRA-PT E108 Blood cholesterol increased
A325	MEDDRA-PT-ID E108 10005425
A326	LLT E108 Cholesterol total increased
A327	LLT-ID E108 10008671
A328	CUI E109 C1522137
A329	UMLS-Preferred-Name E109 Hypertriglyceridemia result
A330	MEDDRA-PT E109 Blood triglycerides increased
A331	MEDDRA-PT-ID E109 10005839
A332	LLT E109 Triglycerides high
A333	LLT-ID E109 10052373
A334	CUI E110 C1522133
A335	UMLS-Preferred-Name E110 Hypercholesterolemia result
A336	MEDDRA-PT E110 Blood cholesterol increased
A337	MEDDRA-PT-ID E110 10005425
A338	LLT E110 Cholesterol total increased
A339	LLT-ID E110 10008671
A340	CUI E111 C1522137
A341	UMLS-Preferred-Name E111 Hypertriglyceridemia result
A342	MEDDRA-PT E111 Blood triglycerides increased
A343	MEDDRA-PT-ID E111 10005839
A344	LLT E111 Triglycerides high
A345	LLT-ID E111 10052373
A346	CUI E112 C0043094
A347	UMLS-Preferred-Name E112 Weight Gain
A348	MEDDRA-PT E112 Weight increased
A349	MEDDRA-PT-ID E112 10047899
A350	CUI E113 C0043094
A351	UMLS-Preferred-Name E113 Weight Gain
A352	MEDDRA-PT E113 Weight increased
A353	MEDDRA-PT-ID E113 10047899
A354	LLT E113 Weight gain
A355	LLT-ID E113 10047896
A356	CUI E114 C0043094
A357	UMLS-Preferred-Name E114 Weight Gain
A358	MEDDRA-PT E114 Weight increased
A359	MEDDRA-PT-ID E114 10047899
A360	LLT E114 Weight gain
A361	LLT-ID E114 10047896
A362	CUI E115 C0043094
A363	UMLS-Preferred-Name E115 Weight Gain
A364	MEDDRA-PT E115 Weight increased
A365	MEDDRA-PT-ID E115 10047899
A366	CUI E116 C0005911
A367	UMLS-Preferred-Name E116 Body Weight Changes
A368	MEDDRA-PT E116 Weight fluctuation
A369	MEDDRA-PT-ID E116 10049040
A370	CUI E117 C0043094
A371	UMLS-Preferred-Name E117 Weight Gain
A372	MEDDRA-PT E117 Weight increased
A373	MEDDRA-PT-ID E117 10047899
A374	LLT E117 Weight gain
A375	LLT-ID E117 10047896
A376	CUI E118 C0043094
A377	UMLS-Preferred-Name E118 Weight Gain
A378	MEDDRA-PT E118 Weight increased
A379	MEDDRA-PT-ID E118 10047899
A380	CUI E119 C0005911
A381	UMLS-Preferred-Name E119 Body Weight Changes
A382	MEDDRA-PT E119 Weight fluctuation
A383	MEDDRA-PT-ID E119 10049040
A384	CUI E120 C0043094
A385	UMLS-Preferred-Name E120 Weight Gain
A386	MEDDRA-PT E120 Weight increased
A387	MEDDRA-PT-ID E120 10047899
A388	LLT E120 Weight gain
A389	LLT-ID E120 10047896
A390	CUI E121 C0043094
A391	UMLS-Preferred-Name E121 Weight Gain
A392	MEDDRA-PT E121 Weight increased
A393	MEDDRA-PT-ID E121 10047899
A394	CUI E122 C0020517
A395	UMLS-Preferred-Name E122 Hypersensitivity
A396	MEDDRA-PT E122 Hypersensitivity
A397	MEDDRA-PT-ID E122 10020751
A398	LLT E122 Hypersensitivity reaction
A399	LLT-ID E122 10020756
A400	CUI E123 C0020517
A401	UMLS-Preferred-Name E123 Hypersensitivity
A402	MEDDRA-PT E123 Hypersensitivity
A403	MEDDRA-PT-ID E123 10020751
A404	LLT E123 Hypersensitivity reaction
A405	LLT-ID E123 10020756
A406	CUI E124 C0002792
A407	UMLS-Preferred-Name E124 anaphylaxis
A408	MEDDRA-PT E124 Anaphylactic reaction
A409	MEDDRA-PT-ID E124 10002198
A410	LLT E124 Anaphylaxis
A411	LLT-ID E124 10002218
A412	CUI E125 C0020649
A413	UMLS-Preferred-Name E125 Hypotension
A414	MEDDRA-PT E125 Hypotension
A415	MEDDRA-PT-ID E125 10021097
A416	CUI E126 C0002994
A417	UMLS-Preferred-Name E126 Angioedema
A418	MEDDRA-PT E126 Angioedema
A419	MEDDRA-PT-ID E126 10002424
A420	CUI E127 C0039231
A421	UMLS-Preferred-Name E127 Tachycardia
A422	MEDDRA-PT E127 Tachycardia
A423	MEDDRA-PT-ID E127 10043071
A424	CUI E128 C0236068
A425	UMLS-Preferred-Name E128 Tongue swelling
A426	MEDDRA-PT E128 Swollen tongue
A427	MEDDRA-PT-ID E128 10042727
A428	CUI E129 C0013404
A429	UMLS-Preferred-Name E129 Dyspnea
A430	MEDDRA-PT E129 Dyspnoea
A431	MEDDRA-PT-ID E129 10013968
A432	LLT E129 Dyspnea
A433	LLT-ID E129 10013963
A434	CUI E130 C0043144
A435	UMLS-Preferred-Name E130 Wheezing
A436	MEDDRA-PT E130 Wheezing
A437	MEDDRA-PT-ID E130 10047924
A438	CUI E131 C0015230
A439	UMLS-Preferred-Name E131 Exanthema
A440	MEDDRA-PT E131 Rash
A441	MEDDRA-PT-ID E131 10037844
A442	CUI E132 C0020651
A443	UMLS-Preferred-Name E132 Hypotension, Orthostatic
A444	MEDDRA-PT E132 Orthostatic hypotension
A445	MEDDRA-PT-ID E132 10031127
A446	CUI E134 C0039070
A447	UMLS-Preferred-Name E134 Syncope
A448	MEDDRA-PT E134 Syncope
A449	MEDDRA-PT-ID E134 10042772
A450	CUI E135 C0039070
A451	UMLS-Preferred-Name E135 Syncope
A452	MEDDRA-PT E135 Syncope
A453	MEDDRA-PT-ID E135 10042772
A454	CUI E136 C0039070
A455	UMLS-Preferred-Name E136 Syncope
A456	MEDDRA-PT E136 Syncope
A457	MEDDRA-PT-ID E136 10042772
A458	CUI E137 C0039070
A459	UMLS-Preferred-Name E137 Syncope
A460	MEDDRA-PT E137 Syncope
A461	MEDDRA-PT-ID E137 10042772
A462	CUI E138 C0039070
A463	UMLS-Preferred-Name E138 Syncope
A464	MEDDRA-PT E138 Syncope
A465	MEDDRA-PT-ID E138 10042772
A466	CUI E139 C0023530
A467	UMLS-Preferred-Name E139 Leukopenia
A468	MEDDRA-PT E139 Leukopenia
A469	MEDDRA-PT-ID E139 10024384
A470	CUI E140 C0027947
A471	UMLS-Preferred-Name E140 Neutropenia
A472	MEDDRA-PT E140 Neutropenia
A473	MEDDRA-PT-ID E140 10029354
A474	CUI E141 C0001824
A475	UMLS-Preferred-Name E141 Agranulocytosis
A476	MEDDRA-PT E141 Agranulocytosis
A477	MEDDRA-PT-ID E141 10001507
A478	CUI E142 C1306577
A479	UMLS-Preferred-Name E142 Death (finding)
A480	MEDDRA-PT E142 Death
A481	MEDDRA-PT-ID E142 10011906
A482	CUI E146 C0855333
A483	UMLS-Preferred-Name E146 Electrocardiogram QT corrected interval prolonged
A484	MEDDRA-PT E146 Electrocardiogram QT prolonged
A485	MEDDRA-PT-ID E146 10014387
A486	LLT E146 Electrocardiogram QTc interval prolonged
A487	LLT-ID E146 10053698
A488	CUI E150 C0855333
A489	UMLS-Preferred-Name E150 Electrocardiogram QT corrected interval prolonged
A490	MEDDRA-PT E150 Electrocardiogram QT prolonged
A491	MEDDRA-PT-ID E150 10014387
A492	LLT E150 Electrocardiogram QTc interval prolonged
A493	LLT-ID E150 10053698
A494	CUI E153 C0855333
A495	UMLS-Preferred-Name E153 Electrocardiogram QT corrected interval prolonged
A496	MEDDRA-PT E153 Electrocardiogram QT prolonged
A497	MEDDRA-PT-ID E153 10014387
A498	LLT E153 Electrocardiogram QTc interval prolonged
A499	LLT-ID E153 10053698
A500	CUI E155 C0151878
A501	UMLS-Preferred-Name E155 Prolonged QT interval
A502	MEDDRA-PT E155 Electrocardiogram QT prolonged
A503	MEDDRA-PT-ID E155 10014387
A504	LLT E155 QT prolonged
A505	LLT-ID E155 10037705
A506	CUI E156 C0040479
A507	UMLS-Preferred-Name E156 Torsades de Pointes
A508	MEDDRA-PT E156 Torsade de pointes
A509	MEDDRA-PT-ID E156 10044066
A510	CUI E158 C0859925
A511	UMLS-Preferred-Name E158 Decreased ventricular repolarisation
A512	MEDDRA-PT E158 Electrocardiogram QT shortened
A513	MEDDRA-PT-ID E158 10014388
A514	LLT E158 Decreased ventricular repolarization
A515	LLT-ID E158 10011981
A516	CUI E159 C0747979
A517	UMLS-Preferred-Name E159 Increased prolactin level
A518	MEDDRA-PT E159 Blood prolactin increased
A519	MEDDRA-PT-ID E159 10005780
A520	LLT E159 Prolactin levels increased
A521	LLT-ID E159 10036828
A522	CUI E162 C0020514
A523	UMLS-Preferred-Name E162 Hyperprolactinemia
A524	MEDDRA-PT E162 Hyperprolactinaemia
A525	MEDDRA-PT-ID E162 10020737
A526	LLT E162 Hyperprolactinemia
A527	LLT-ID E162 10020739
A528	CUI E163 C4025644
A529	UMLS-Preferred-Name E163 Hypothalamic gonadotropin-releasing hormone (GNRH) deficiency
A530	MEDDRA-PT E163 Blood gonadotrophin decreased
A531	MEDDRA-PT-ID E163 10005562
A532	LLT E163 Gonadotropins decreased
A533	LLT-ID E163 10018546
A534	CUI E164 C0151676
A535	UMLS-Preferred-Name E164 Pituitary gonadotrophin decreased
A536	MEDDRA-PT E164 Blood gonadotrophin decreased
A537	MEDDRA-PT-ID E164 10005562
A538	LLT E164 Pituitary gonadotrophin decreased
A539	LLT-ID E164 10054718
A540	CUI E165 C1558153
A541	UMLS-Preferred-Name E165 Adverse Event Associated with Sexual and Reproductive Function
A542	MEDDRA-PT E165 Reproductive toxicity
A543	MEDDRA-PT-ID E165 10074268
A544	flag E167 underspecified
A545	CUI E167 C2242620
A546	UMLS-Preferred-Name E167 Gonadal insufficiency
A547	MEDDRA-PT E167 Hypogonadism
A548	MEDDRA-PT-ID E167 10058359
A549	LLT E167 Gonadal insufficiency
A550	LLT-ID E167 10068037
A551	CUI E168 C3665358
A552	UMLS-Preferred-Name E168 Galactorrhea
A553	MEDDRA-PT E168 Galactorrhoea
A554	MEDDRA-PT-ID E168 10017600
A555	LLT E168 Galactorrhea
A556	LLT-ID E168 10017592
A557	CUI E169 C0002453
A558	UMLS-Preferred-Name E169 Amenorrhea
A559	MEDDRA-PT E169 Amenorrhoea
A560	MEDDRA-PT-ID E169 10001928
A561	LLT E169 Amenorrhea
A562	LLT-ID E169 10001927
A563	CUI E170 C0018418
A564	UMLS-Preferred-Name E170 Gynecomastia
A565	MEDDRA-PT E170 Gynaecomastia
A566	MEDDRA-PT-ID E170 10018800
A567	LLT E170 Gynecomastia
A568	LLT-ID E170 10018801
A569	CUI E171 C0242350
A570	UMLS-Preferred-Name E171 Erectile dysfunction
A571	MEDDRA-PT E171 Erectile dysfunction
A572	MEDDRA-PT-ID E171 10061461
A573	LLT E171 Impotence
A574	LLT-ID E171 10021550
A575	CUI E173 C0020514
A576	UMLS-Preferred-Name E173 Hyperprolactinemia
A577	MEDDRA-PT E173 Hyperprolactinaemia
A578	MEDDRA-PT-ID E173 10020737
A579	LLT E173 Hyperprolactinemia
A580	LLT-ID E173 10020739
A581	CUI E174 C0020619
A582	UMLS-Preferred-Name E174 Hypogonadism
A583	MEDDRA-PT E174 Hypogonadism
A584	MEDDRA-PT-ID E174 10058359
A585	CUI E175 C0877225
A586	UMLS-Preferred-Name E175 Bone density decreased
A587	MEDDRA-PT E175 Bone density decreased
A588	MEDDRA-PT-ID E175 10049470
A589	CUI E177 C4022448
A590	UMLS-Preferred-Name E177 Abnormal prolactin level
A591	MEDDRA-PT E177 Blood prolactin abnormal
A592	MEDDRA-PT-ID E177 10005778
A593	LLT E177 Prolactin abnormal NOS
A594	LLT-ID E177 10036823
A595	CUI E178 C4022448
A596	UMLS-Preferred-Name E178 Abnormal prolactin level
A597	MEDDRA-PT E178 Blood prolactin abnormal
A598	MEDDRA-PT-ID E178 10005778
A599	LLT E178 Prolactin abnormal NOS
A600	LLT-ID E178 10036823
A601	CUI E179 C0036572
A602	UMLS-Preferred-Name E179 Seizures
A603	MEDDRA-PT E179 Seizure
A604	MEDDRA-PT-ID E179 10039906
A605	LLT E179 Seizures
A606	LLT-ID E179 10039910
A607	CUI E180 C0036572
A608	UMLS-Preferred-Name E180 Seizures
A609	MEDDRA-PT E180 Seizure
A610	MEDDRA-PT-ID E180 10039906
A611	LLT E180 Seizures
A612	LLT-ID E180 10039910
A613	CUI E181 C0036572
A614	UMLS-Preferred-Name E181 Seizures
A615	MEDDRA-PT E181 Seizure
A616	MEDDRA-PT-ID E181 10039906
A617	LLT E181 Seizures
A618	LLT-ID E181 10039910
A619	CUI E183 C2830004
A620	UMLS-Preferred-Name E183 Somnolence
A621	MEDDRA-PT E183 Somnolence
A622	MEDDRA-PT-ID E183 10041349
A623	CUI E184 C2830004
A624	UMLS-Preferred-Name E184 Somnolence
A625	MEDDRA-PT E184 Somnolence
A626	MEDDRA-PT-ID E184 10041349
A627	CUI E185 C2830004
A628	UMLS-Preferred-Name E185 Somnolence
A629	MEDDRA-PT E185 Somnolence
A630	MEDDRA-PT-ID E185 10041349
A631	CUI E186 C2830004
A632	UMLS-Preferred-Name E186 Somnolence
A633	MEDDRA-PT E186 Somnolence
A634	MEDDRA-PT-ID E186 10041349
A635	CUI E187 C2830004
A636	UMLS-Preferred-Name E187 Somnolence
A637	MEDDRA-PT E187 Somnolence
A638	MEDDRA-PT-ID E187 10041349
A639	CUI E188 C0235195
A640	UMLS-Preferred-Name E188 Sedated state
A641	MEDDRA-PT E188 Sedation
A642	MEDDRA-PT-ID E188 10039897
A643	CUI E189 C2830004
A644	UMLS-Preferred-Name E189 Somnolence
A645	MEDDRA-PT E189 Somnolence
A646	MEDDRA-PT-ID E189 10041349
A647	CUI E190 C0235195
A648	UMLS-Preferred-Name E190 Sedated state
A649	MEDDRA-PT E190 Sedation
A650	MEDDRA-PT-ID E190 10039897
A651	CUI E191 C0917799
A652	UMLS-Preferred-Name E191 Hypersomnia
A653	MEDDRA-PT E191 Hypersomnia
A654	MEDDRA-PT-ID E191 10020765
A655	CUI E192 C2830004
A656	UMLS-Preferred-Name E192 Somnolence
A657	MEDDRA-PT E192 Somnolence
A658	MEDDRA-PT-ID E192 10041349
A659	CUI E193 C0854171
A660	UMLS-Preferred-Name E193 Temperature regulation disorder
A661	MEDDRA-PT E193 Temperature regulation disorder
A662	MEDDRA-PT-ID E193 10061376
A663	CUI E195 C0015967
A664	UMLS-Preferred-Name E195 Fever
A665	MEDDRA-PT E195 Body temperature increased
A666	MEDDRA-PT-ID E195 10005911
A667	CUI E196 C0015967
A668	UMLS-Preferred-Name E196 Fever
A669	MEDDRA-PT E196 Body temperature increased
A670	MEDDRA-PT-ID E196 10005911
A671	CUI E197 C0015967
A672	UMLS-Preferred-Name E197 Fever
A673	MEDDRA-PT E197 Pyrexia
A674	MEDDRA-PT-ID E197 10037660
A675	CUI E198 C2939147
A676	UMLS-Preferred-Name E198 Feels hot
A677	MEDDRA-PT E198 Feeling hot
A678	MEDDRA-PT-ID E198 10016334
A679	CUI E199 C0014858
A680	UMLS-Preferred-Name E199 Esophageal motility disorders
A681	MEDDRA-PT E199 Oesophageal motility disorder
A682	MEDDRA-PT-ID E199 10072419
A683	LLT E199 Esophageal motility disorder
A684	LLT-ID E199 10072420
A685	CUI E200 C0700198
A686	UMLS-Preferred-Name E200 Pulmonary aspiration
A687	MEDDRA-PT E200 Aspiration
A688	MEDDRA-PT-ID E200 10003504
A689	CUI E202 C0011168
A690	UMLS-Preferred-Name E202 Deglutition Disorders
A691	MEDDRA-PT E202 Dysphagia
A692	MEDDRA-PT-ID E202 10013950
A693	CUI E203 C0011168
A694	UMLS-Preferred-Name E203 Deglutition Disorders
A695	MEDDRA-PT E203 Dysphagia
A696	MEDDRA-PT-ID E203 10013950
A697	CUI E212 C0043094
A698	UMLS-Preferred-Name E212 Weight Gain
A699	MEDDRA-PT E212 Weight increased
A700	MEDDRA-PT-ID E212 10047899
A701	CUI E214 C0027849
A702	UMLS-Preferred-Name E214 Neuroleptic Malignant Syndrome
A703	MEDDRA-PT E214 Neuroleptic malignant syndrome
A704	MEDDRA-PT-ID E214 10029282
A705	CUI E215 C0686347
A706	UMLS-Preferred-Name E215 Tardive Dyskinesia
A707	MEDDRA-PT E215 Tardive dyskinesia
A708	MEDDRA-PT-ID E215 10043118
A709	CUI E216 C0151878
A710	UMLS-Preferred-Name E216 Prolonged QT interval
A711	MEDDRA-PT E216 Electrocardiogram QT prolonged
A712	MEDDRA-PT-ID E216 10014387
A713	LLT E216 QT interval prolonged
A714	LLT-ID E216 10037703
A715	CUI E217 C0036572
A716	UMLS-Preferred-Name E217 Seizures
A717	MEDDRA-PT E217 Seizure
A718	MEDDRA-PT-ID E217 10039906
A719	LLT E217 Seizures
A720	LLT-ID E217 10039910
A721	CUI E218 C0338656
A722	UMLS-Preferred-Name E218 Impaired cognition
A723	MEDDRA-PT E218 Cognitive disorder
A724	MEDDRA-PT-ID E218 10057668
A725	LLT E218 Cognitive impairment
A726	LLT-ID E218 10009846
A727	CUI E220 C0221163
A728	UMLS-Preferred-Name E220 Motor Disorders
A729	MEDDRA-PT E220 Motor dysfunction
A730	MEDDRA-PT-ID E220 10061296
A731	CUI E221 C0038661
A732	UMLS-Preferred-Name E221 Suicide
A733	MEDDRA-PT E221 Completed suicide
A734	MEDDRA-PT-ID E221 10010144
A735	LLT E221 Suicide
A736	LLT-ID E221 10042462
A737	CUI E223 C0025517
A738	UMLS-Preferred-Name E223 Metabolic Diseases
A739	MEDDRA-PT E223 Metabolic disorder
A740	MEDDRA-PT-ID E223 10058097
A741	CUI E224 C0039070
A742	UMLS-Preferred-Name E224 Syncope
A743	MEDDRA-PT E224 Syncope
A744	MEDDRA-PT-ID E224 10042772
A745	CUI E29 C1306577
A746	UMLS-Preferred-Name E29 Death (finding)
A747	MEDDRA-PT E29 Death
A748	MEDDRA-PT-ID E29 10011906
A749	CUI E78 C0020456
A750	UMLS-Preferred-Name E78 Hyperglycemia
A751	MEDDRA-PT E78 Hyperglycaemia
A752	MEDDRA-PT-ID E78 10020635
A753	LLT E78 Hyperglycemia
A754	LLT-ID E78 10020639
A755	CUI E226 C0043094
A756	UMLS-Preferred-Name E226 Weight Gain
A757	MEDDRA-PT E226 Weight increased
A758	MEDDRA-PT-ID E226 10047899
A759	CUI E228 C0043094
A760	UMLS-Preferred-Name E228 Weight Gain
A761	MEDDRA-PT E228 Weight increased
A762	MEDDRA-PT-ID E228 10047899
A763	CUI E231 C0007621
A764	UMLS-Preferred-Name E231 Neoplastic Cell Transformation
A765	MEDDRA-PT E231 Carcinogenicity
A766	MEDDRA-PT-ID E231 10007269
A767	CUI E234 C0007820
A768	UMLS-Preferred-Name E234 Cerebrovascular Disorders
A769	MEDDRA-PT E234 Cerebrovascular disorder
A770	MEDDRA-PT-ID E234 10008196
A771	CUI E235 C0025517
A772	UMLS-Preferred-Name E235 Metabolic Diseases
A773	MEDDRA-PT E235 Metabolic disorder
A774	MEDDRA-PT-ID E235 10058097
A775	CUI E236 C0020517
A776	UMLS-Preferred-Name E236 Hypersensitivity
A777	MEDDRA-PT E236 Hypersensitivity
A778	MEDDRA-PT-ID E236 10020751
A779	LLT E236 Hypersensitivity reaction
A780	LLT-ID E236 10020756
A781	CUI E237 C0020651
A782	UMLS-Preferred-Name E237 Hypotension, Orthostatic
A783	MEDDRA-PT E237 Orthostatic hypotension
A784	MEDDRA-PT-ID E237 10031127
A785	CUI E238 C0039070
A786	UMLS-Preferred-Name E238 Syncope
A787	MEDDRA-PT E238 Syncope
A788	MEDDRA-PT-ID E238 10042772
A789	CUI E239 C0948268
A790	UMLS-Preferred-Name E239 Hemodynamic instability
A791	MEDDRA-PT E239 Haemodynamic instability
A792	MEDDRA-PT-ID E239 10052076
A793	LLT E239 Hemodynamic instability
A794	LLT-ID E239 10058270
A795	CUI E240 C0151878
A796	UMLS-Preferred-Name E240 Prolonged QT interval
A797	MEDDRA-PT E240 Electrocardiogram QT prolonged
A798	MEDDRA-PT-ID E240 10014387
A799	LLT E240 QT prolonged
A800	LLT-ID E240 10037705
